151 related articles for article (PubMed ID: 16329994)
1. The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase.
Wei P; Fan K; Chen H; Ma L; Huang C; Tan L; Xi D; Li C; Liu Y; Cao A; Lai L
Biochem Biophys Res Commun; 2006 Jan; 339(3):865-72. PubMed ID: 16329994
[TBL] [Abstract][Full Text] [Related]
2. The substrate specificity of SARS coronavirus 3C-like proteinase.
Fan K; Ma L; Han X; Liang H; Wei P; Liu Y; Lai L
Biochem Biophys Res Commun; 2005 Apr; 329(3):934-40. PubMed ID: 15752746
[TBL] [Abstract][Full Text] [Related]
3. Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations.
Chen S; Chen L; Tan J; Chen J; Du L; Sun T; Shen J; Chen K; Jiang H; Shen X
J Biol Chem; 2005 Jan; 280(1):164-73. PubMed ID: 15507456
[TBL] [Abstract][Full Text] [Related]
4. Residues on the dimer interface of SARS coronavirus 3C-like protease: dimer stability characterization and enzyme catalytic activity analysis.
Chen S; Zhang J; Hu T; Chen K; Jiang H; Shen X
J Biochem; 2008 Apr; 143(4):525-36. PubMed ID: 18182387
[TBL] [Abstract][Full Text] [Related]
5. Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors.
Shi J; Wei Z; Song J
J Biol Chem; 2004 Jun; 279(23):24765-73. PubMed ID: 15037623
[TBL] [Abstract][Full Text] [Related]
6. Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase.
Liu Z; Huang C; Fan K; Wei P; Chen H; Liu S; Pei J; Shi L; Li B; Yang K; Liu Y; Lai L
J Chem Inf Model; 2005; 45(1):10-17. PubMed ID: 15667124
[TBL] [Abstract][Full Text] [Related]
7. The interaction between severe acute respiratory syndrome coronavirus 3C-like proteinase and a dimeric inhibitor by capillary electrophoresis.
Ding L; Zhang XX; Wei P; Fan K; Lai L
Anal Biochem; 2005 Aug; 343(1):159-65. PubMed ID: 15935325
[TBL] [Abstract][Full Text] [Related]
8. Maturation mechanism of severe acute respiratory syndrome (SARS) coronavirus 3C-like proteinase.
Li C; Qi Y; Teng X; Yang Z; Wei P; Zhang C; Tan L; Zhou L; Liu Y; Lai L
J Biol Chem; 2010 Sep; 285(36):28134-40. PubMed ID: 20489209
[TBL] [Abstract][Full Text] [Related]
9. Mutation of Gly-11 on the dimer interface results in the complete crystallographic dimer dissociation of severe acute respiratory syndrome coronavirus 3C-like protease: crystal structure with molecular dynamics simulations.
Chen S; Hu T; Zhang J; Chen J; Chen K; Ding J; Jiang H; Shen X
J Biol Chem; 2008 Jan; 283(1):554-564. PubMed ID: 17977841
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase.
Fan K; Wei P; Feng Q; Chen S; Huang C; Ma L; Lai B; Pei J; Liu Y; Chen J; Lai L
J Biol Chem; 2004 Jan; 279(3):1637-42. PubMed ID: 14561748
[TBL] [Abstract][Full Text] [Related]
11. Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase.
Lai L; Han X; Chen H; Wei P; Huang C; Liu S; Fan K; Zhou L; Liu Z; Pei J; Liu Y
Curr Pharm Des; 2006; 12(35):4555-64. PubMed ID: 17168761
[TBL] [Abstract][Full Text] [Related]
12. Mutation of Asn28 disrupts the dimerization and enzymatic activity of SARS 3CL(pro) .
Barrila J; Gabelli SB; Bacha U; Amzel LM; Freire E
Biochemistry; 2010 May; 49(20):4308-17. PubMed ID: 20420403
[TBL] [Abstract][Full Text] [Related]
13. Mutational and inhibitive analysis of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer-based assays.
Kuang WF; Chow LP; Wu MH; Hwang LH
Biochem Biophys Res Commun; 2005 Jun; 331(4):1554-9. PubMed ID: 15883050
[TBL] [Abstract][Full Text] [Related]
14. 3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism.
Huang C; Wei P; Fan K; Liu Y; Lai L
Biochemistry; 2004 Apr; 43(15):4568-74. PubMed ID: 15078103
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro.
Jain RP; Pettersson HI; Zhang J; Aull KD; Fortin PD; Huitema C; Eltis LD; Parrish JC; James MN; Wishart DS; Vederas JC
J Med Chem; 2004 Dec; 47(25):6113-6. PubMed ID: 15566280
[TBL] [Abstract][Full Text] [Related]
16. [Modeling of the SARS coronavirus main proteinase and conformational flexibility of the active site].
Liu S; Pei J; Chen H; Zhu X; Liu Z; Ma W; He F; Lai L
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 May; 35 Suppl():62-5. PubMed ID: 12914221
[TBL] [Abstract][Full Text] [Related]
17. Mutation of Glu-166 blocks the substrate-induced dimerization of SARS coronavirus main protease.
Cheng SC; Chang GG; Chou CY
Biophys J; 2010 Apr; 98(7):1327-36. PubMed ID: 20371333
[TBL] [Abstract][Full Text] [Related]
18. Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease.
Liu YC; Huang V; Chao TC; Hsiao CD; Lin A; Chang MF; Chow LP
Biochem Biophys Res Commun; 2005 Jul; 333(1):194-9. PubMed ID: 15950190
[TBL] [Abstract][Full Text] [Related]
19. Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer.
Xu T; Ooi A; Lee HC; Wilmouth R; Liu DX; Lescar J
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Nov; 61(Pt 11):964-6. PubMed ID: 16511208
[TBL] [Abstract][Full Text] [Related]
20. Only one protomer is active in the dimer of SARS 3C-like proteinase.
Chen H; Wei P; Huang C; Tan L; Liu Y; Lai L
J Biol Chem; 2006 May; 281(20):13894-8. PubMed ID: 16565086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
